Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Abzena and OBI Pharma Sign ThioBridgeâ„¢ Licence Agreement

Wednesday, July 12, 2017

Abzena plc the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products has signed a licensing agreement and a master services and clinical supply agreement with OBI Pharma a Taiw...

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center

Wednesday, July 12, 2017

CURE Pharmaceutical a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company and Therapix Biosciences a specialty clinicalstage pharmaceutical company dedicated to the development of cannabinoidbased d...

Race Oncology Limited Joint Venture With TargImmune

Tuesday, July 11, 2017

Race Oncology Limited announced that it has executed a Letter of Intent with TargImmune Therapeutics AG Basel Switzerland to enter into a joint venture between the two companies The joint venture to be called Race Immunotherapeutics will focus on dev...

InMed Pharmaceuticals Signs R&D Agreement with ATERA

Tuesday, July 11, 2017

InMed Pharmaceuticals Inc a biopharmaceutical company specializing in the research and development of novel cannabinoidbased drug therapies is pleased to announce it has entered into a research and development collaboration with ATERA SAS of France a...

Capricor Therapeutics Retains Full Rights to CAP-1002 as Janssen Biotech, Inc. Decides Not to Exercise Option

Monday, July 10, 2017

Capricor Therapeutics Inc announced that Janssen Biotech Inc Janssen has decided not to exercise its option to exclusively license Capricors lead candidate CAP allogeneic cardiospherederived cells for development and commercialization in the field of...

Eurofins Has Signed an Exclusive Agreement to Acquire Amatsigroup

Monday, July 10, 2017

Eurofins Scientific a global leader in biopharmaceutical products testing and one of the world leaders in genomic services announces that it has signed an exclusive agreement with Ekkio Capital to acquire the Amatsigroup for a price of approximately...

InDex Pharmaceuticals Gets New Patent Granted in Europe

Friday, July 07, 2017

InDex Pharmaceuticals Holding AB publ announced that a new method of use patent for the drug candidate cobitolimod has been granted by the European Patent Office The patent provides additional protection for the use of cobitolimod for the treatment o...

Oxford BioMedica Announces a Major Supply Agreement

Friday, July 07, 2017

Oxford BioMedica plc a leading gene and cell therapy group today announces that it has signed an agreement with Novartis for the commercial and clinical supply of lentiviral vectors used to generate CTL tisagenlecleucel and other undisclosed Chimeric...

RDD Pharma Receives Orphan Designation for RDD-0315

Thursday, July 06, 2017

RDD Pharma a leader in developing treatments for anorectal disorders announced today the European Medicines Agencys Committee for Orphan Medicinal Products has granted orphan designation for RDD an investigational drug for the treatment of fecal inco...

Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration with BeiGene

Thursday, July 06, 2017

Celgene Corporation and BeiGene Ltd entered into a strategic collaboration to develop and commercialize BeiGenes investigational antiprogrammed cell death protein PD inhibitor BGBA for patients with solid tumor cancers in the United States Europe Ja...